These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17348745)

  • 1. Community-directed treatment of lymphatic filariasis in Kenya and its role in the national programmes for elimination of lymphatic filariasis.
    Wamae N; Njenga SM; Kisingu WM; Muthigani PW; Kiiru K
    Afr J Health Sci; 2006; 13(1-2):69-79. PubMed ID: 17348745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community-directed treatment: the way forward to eliminating lymphatic filariasis as a public-health problem in Ghana.
    Gyapong M; Gyapong JO; Owusu-Banahene G
    Ann Trop Med Parasitol; 2001 Jan; 95(1):77-86. PubMed ID: 11235557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The fight against lymphatic filariasis: perceptions of community drug distributors during mass drug administration in coastal Kenya.
    Kusi C; Steinmann P; Merten S
    Infect Dis Poverty; 2020 Mar; 9(1):22. PubMed ID: 32114985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation challenges and opportunities for improved mass treatment uptake for lymphatic filariasis elimination: Perceptions and experiences of community drug distributors of coastal Kenya.
    Njomo DW; Kimani BW; Kibe LW; Okoyo C; Omondi WP; Sultani HM
    PLoS Negl Trop Dis; 2020 Dec; 14(12):e0009012. PubMed ID: 33370300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of community and health services-organized drug delivery strategies for elimination of lymphatic filariasis in rural areas of Tamil Nadu, India.
    Ramaiah KD; Vijay Kumar KN; Chandrakala AV; Augustin DJ; Appavoo NC; Das PK
    Trop Med Int Health; 2001 Dec; 6(12):1062-9. PubMed ID: 11737843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demographic and socio-economic factors with implications for the control of lymphatic filariasis in Kwale District, Kenya.
    Mwobobia IK; Mitsui Y
    East Afr Med J; 1999 Sep; 76(9):495-8. PubMed ID: 10685317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of personal opinions and experiences in compliance with mass drug administration for lymphatic filariasis elimination in Kenya.
    Njomo DW; Amuyunzu-Nyamongo M; Magambo JK; Njenga SM
    PLoS One; 2012; 7(11):e48395. PubMed ID: 23185256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards elimination of lymphatic filariasis: social mobilization issues and challenges in mass drug administration with anti-filarial drugs in Tamil Nadu, South India.
    Nandha B; Krishnamoorthy K; Jambulingam P
    Health Educ Res; 2013 Aug; 28(4):591-8. PubMed ID: 23503571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review of factors that shape implementation of mass drug administration for lymphatic filariasis in sub-Saharan Africa.
    Silumbwe A; Zulu JM; Halwindi H; Jacobs C; Zgambo J; Dambe R; Chola M; Chongwe G; Michelo C
    BMC Public Health; 2017 May; 17(1):484. PubMed ID: 28532397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strengthening of mass drug administration implementation is required to eliminate lymphatic filariasis from India: an evaluation study.
    Lahariya C; Mishra A
    J Vector Borne Dis; 2008 Dec; 45(4):313-20. PubMed ID: 19248659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing coverage in mass drug administration for lymphatic filariasis elimination in an urban setting: a study of Malindi Town, Kenya.
    Njomo DW; Mukoko DA; Nyamongo NK; Karanja J
    PLoS One; 2014; 9(1):e83413. PubMed ID: 24454703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphatic filariasis in kenya since 1910, and the prospects for its elimination: a review.
    Wamae CN; Mwandawiro C; Wambayi E; Njenga S; Kiliku F
    East Afr Med J; 2001 Nov; 78(11):595-603. PubMed ID: 12219966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community perceptions on the community-directed treatment and school-based approaches for the control of schistosomiasis and soil-transmitted helminthiasis among school-age children in Lushoto District, Tanzania.
    Massa K; Magnussen P; Sheshe A; Ntakamulenga R; Ndawi B; Olsen A
    J Biosoc Sci; 2009 Jan; 41(1):89-105. PubMed ID: 18647439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Community-directed treatment of onchocerciasis with ivermectin in Takum, Nigeria.
    Akogun OB; Audu Z; Weiss MG; Adelakun AO; Akoh JI; Akogun MK; Remme H; Kale OO
    Trop Med Int Health; 2001 Mar; 6(3):232-43. PubMed ID: 11299041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of a triple-drug regimen for global elimination of lymphatic filariasis: a modelling study.
    Irvine MA; Stolk WA; Smith ME; Subramanian S; Singh BK; Weil GJ; Michael E; Hollingsworth TD
    Lancet Infect Dis; 2017 Apr; 17(4):451-458. PubMed ID: 28012943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated community-directed treatment for the control of onchocerciasis, schistosomiasis and intestinal helminths infections in Uganda: advantages and disadvantages.
    Ndyomugyenyi R; Kabatereine N
    Trop Med Int Health; 2003 Nov; 8(11):997-1004. PubMed ID: 14629766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community-directed distributors-The "foot soldiers" in the fight to control and eliminate neglected tropical diseases.
    Amazigo UV; Leak SGA; Zoure HGM; Okoronkwo C; Diop Ly M; Isiyaku S; Crump A; Okeibunor JC; Boatin B
    PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009088. PubMed ID: 33661903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Keeping communities at the centre of efforts to eliminate lymphatic filariasis: learning from the past to reach a future free of lymphatic filariasis.
    Krentel A; Gyapong M; McFarland DA; Ogundahunsi O; Titaley CR; Addiss DG
    Int Health; 2020 Dec; 13(Supplement_1):S55-S59. PubMed ID: 33349882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elimination of lymphatic filariasis: do we have the drugs to complete the job?
    Bockarie MJ; Deb RM
    Curr Opin Infect Dis; 2010 Dec; 23(6):617-20. PubMed ID: 20847694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addressing barriers of community participation and access to mass drug administration for lymphatic filariasis elimination in Coastal Kenya using a participatory approach.
    Njomo DW; Kibe LW; Kimani BW; Okoyo C; Omondi WP; Sultani HM
    PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008499. PubMed ID: 32936792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.